CanSino Biologics Inc. (688185.SS)

CNY 56.85

(4.33%)

Gross Profit Summary of CanSino Biologics Inc.

  • CanSino Biologics Inc.'s latest annual gross profit in 2023 was -876.01 Million CNY , up 88.3% from previous year.
  • CanSino Biologics Inc.'s latest quarterly gross profit in 2024 Q3 was 206.21 Million CNY , up 85.29% from previous quarter.
  • CanSino Biologics Inc. reported a annual gross profit of -186.6 Million CNY in annual gross profit 2022, down -106.21% from previous year.
  • CanSino Biologics Inc. reported a annual gross profit of 3 Billion CNY in annual gross profit 2021, up 63258.99% from previous year.
  • CanSino Biologics Inc. reported a quarterly gross profit of 111.29 Million CNY for 2024 Q2, up 68.42% from previous quarter.
  • CanSino Biologics Inc. reported a quarterly gross profit of 206.21 Million CNY for 2024 Q3, up 85.29% from previous quarter.

Annual Gross Profit Chart of CanSino Biologics Inc. (2023 - 2016)

Historical Annual Gross Profit of CanSino Biologics Inc. (2023 - 2016)

Year Gross Profit Gross Profit Growth
2023 -876.01 Million CNY 88.3%
2022 -186.6 Million CNY -106.21%
2021 3 Billion CNY 63258.99%
2020 4.74 Million CNY 121.92%
2019 2.13 Million CNY 101.9%
2018 -112.51 Million CNY -63.77%
2017 -68.7 Million CNY -58.04%
2016 -43.47 Million CNY 0.0%

Peer Gross Profit Comparison of CanSino Biologics Inc.

Name Gross Profit Gross Profit Difference
Shanghai Haoyuan Chemexpress Co., Ltd. 759.03 Million CNY 215.413%
Hubei Jumpcan Pharmaceutical Co., Ltd. 7.74 Billion CNY 111.311%
Yabao Pharmaceutical Group Co., Ltd 1.66 Billion CNY 152.639%
Shandong Lukang Pharmaceutical Co.,Ltd. 1.46 Billion CNY 159.97%
Zhejiang Huahai Pharmaceutical Co., Ltd. 4.83 Billion CNY 118.115%
Tasly Pharmaceutical Group Co., Ltd 5.66 Billion CNY 115.477%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 3.59 Billion CNY 124.401%
Lionco Pharmaceutical Group Co.,Ltd. 86.95 Million CNY 1107.434%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 361.03 Million CNY 342.639%
China Animal Husbandry Industry Co., Ltd. 1.06 Billion CNY 181.983%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 3.61 Billion CNY 124.25%
Zhejiang Shengda Bio-Pharm Co., Ltd. 74.18 Million CNY 1280.867%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 1.65 Billion CNY 152.927%
Henan Lingrui Pharmaceutical Co., Ltd. 2.42 Billion CNY 136.093%
Guizhou Yibai Pharmaceutical Co., Ltd. 1.84 Billion CNY 147.554%
Zhongzhu Healthcare Holding Co.,Ltd -114.92 Million CNY -662.239%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 735.98 Million CNY 219.026%
Jianmin Pharmaceutical Group Co.,Ltd. 1.88 Billion CNY 146.56%
North China Pharmaceutical Company Ltd. 3.21 Billion CNY 127.263%
Zhejiang Hisun Pharmaceutical Co., Ltd. 4.18 Billion CNY 120.936%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 1.32 Billion CNY 165.999%
ChengDu ShengNuo Biotec Co.,Ltd. 267.6 Million CNY 427.353%
Dali Pharmaceuticalco.,Ltd 36.29 Million CNY 2513.484%
Harbin Pharmaceutical Group Co., Ltd. 3.76 Billion CNY 123.256%
Zhejiang Medicine Co., Ltd. 2.52 Billion CNY 134.704%
HPGC Renmintongtai Pharmaceutical Corporation 986.11 Million CNY 188.835%
Humanwell Healthcare (Group) Co.,Ltd. 10.65 Billion CNY 108.222%
Ginwa Enterprise (Group) Inc. 431.65 Million CNY 302.946%
KPC Pharmaceuticals, Inc. 3.33 Billion CNY 126.268%
Changchun BCHT Biotechnology Co. 1.6 Billion CNY 154.707%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 765.77 Million CNY 214.396%
Ningbo Menovo Pharmaceutical Co., Ltd. 342.7 Million CNY 355.618%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 2.07 Billion CNY 142.118%
Nanjing Well Pharmaceutical Group Co.,Ltd. 312.86 Million CNY 379.995%
Joincare Pharmaceutical Group Industry Co.,Ltd. 9.79 Billion CNY 108.943%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 5.61 Billion CNY 115.601%
Chongqing Taiji Industry(Group) Co.,Ltd 7.13 Billion CNY 112.273%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 13.54 Billion CNY 106.467%
China National Medicines Corporation Ltd. 3.85 Billion CNY 122.742%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 431.02 Million CNY 303.239%
Shenzhen Chipscreen Biosciences Co., Ltd. 433.54 Million CNY 302.059%
Beijing Tongrentang Co., Ltd 8.3 Billion CNY 110.549%
Tibet Weixinkang Medicine Co., Ltd. 672.1 Million CNY 230.34%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 19.8 Billion CNY 104.423%
Hunan Fangsheng Pharmaceutical Co., Ltd. 1.1 Billion CNY 179.185%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 1.9 Billion CNY 146.034%
Shanghai Jiaoda Onlly Co.,Ltd 62.19 Million CNY 1508.474%
Jiang Zhong Pharmaceutical Co.,Ltd 2.74 Billion CNY 131.881%
Guobang Pharma Ltd. 1.2 Billion CNY 172.467%
Mayinglong Pharmaceutical Group Co., LTD. 1.3 Billion CNY 167.012%
Cisen Pharmaceutical Co., Ltd. 2.54 Billion CNY 134.358%
Hunan Warrant Pharmaceutical Co.,Ltd 928.23 Million CNY 194.375%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 183.75 Million CNY 576.745%
Shandong Buchang Pharmaceuticals Co., Ltd. 8.7 Billion CNY 110.066%
Zhejiang Starry Pharmaceutical Co.,Ltd. 464.77 Million CNY 288.48%
Kangmei Pharmaceutical Co., Ltd. 715.07 Million CNY 222.508%
Henan Taloph Pharmaceutical Stock Co.,Ltd 538.56 Million CNY 262.658%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 1.74 Billion CNY 150.116%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 659.13 Million CNY 232.904%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 528.34 Million CNY 265.803%
Shanghai Shyndec Pharmaceutical Co., Ltd. 4.39 Billion CNY 119.936%
Shanghai Yizhong Pharmaceutical Co., Ltd. 336.2 Million CNY 360.564%
Tibet Rhodiola Pharmaceutical Holding Co. 2.94 Billion CNY 129.786%
Sichuan Huiyu Pharmaceutical Co., Ltd. 787.59 Million CNY 211.227%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 1.04 Billion CNY 183.91%